ergotamine (BioDeep_00000408551)

   


代谢物信息卡片


Ergotaminum

化学式: C33H35N5O5 (581.263806)
中文名称: 麦角胺
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C
InChI: InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1

描述信息

A peptide ergot alkaloid that is dihydroergotamine in which a double bond replaces the single bond between positions 9 and 10.
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CA - Ergot alkaloids
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist > C61751 - Ergotamine
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
D002491 - Central Nervous System Agents > D000700 - Analgesics
D012102 - Reproductive Control Agents > D010120 - Oxytocics
CONFIDENCE Claviceps purpurea sclerotia

同义名列表

2 个代谢物同义名

ergotamine; Ergotaminum



数据库引用编号

20 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

8 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Priyanka Reddy, Joanne Hemsworth, Kathryn M Guthridge, Antony Vinh, Simone Vassiliadis, Vilnis Ezernieks, German C Spangenberg, Simone J Rochfort. Ergot alkaloid mycotoxins: physiological effects, metabolism and distribution of the residual toxin in mice. Scientific reports. 2020 06; 10(1):9714. doi: 10.1038/s41598-020-66358-2. [PMID: 32546814]
  • M D Combs, S H Edwards, J M Scherpenhuizen, E J Narayan, A E Kessell, J Ramsay, J Piltz, S R Raidal, J C Quinn. Treatment with potassium bromide mitigates ataxia and reduces tremor in lambs with perennial ryegrass toxicosis. New Zealand veterinary journal. 2019 Nov; 67(6):287-294. doi: 10.1080/00480169.2019.1637300. [PMID: 31248334]
  • Wiebke Rudolph, Daniela Remane, Dirk K Wissenbach, Frank T Peters. Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations. Xenobiotica; the fate of foreign compounds in biological systems. 2019 Oct; 49(10):1149-1157. doi: 10.1080/00498254.2018.1542187. [PMID: 30623698]
  • M D Combs, S H Edwards, J M Scherpenhuizen, E J Narayan, A E Kessell, J Piltz, S R Raidal, J Ramsay, J C Quinn. Development of a model for investigation of perennial ryegrass toxicosis in sheep. New Zealand veterinary journal. 2018 Nov; 66(6):281-289. doi: 10.1080/00480169.2018.1492986. [PMID: 29949720]
  • Matevž Likar, Marjana Grandič, Breda Jakovac Strajn, Katarina Kos, Franci Aco Celar. Links Between Genetic Groups, Host Specificity, and Ergot-Alkaloid Profiles within Claviceps purpurea (Fr.) Tul. on Slovenian Grasses. Plant disease. 2018 Jul; 102(7):1334-1340. doi: 10.1094/pdis-08-17-1179-re. [PMID: 30673578]
  • H K Sran, A Vathsala. Renal infarction due to ergotamine. QJM : monthly journal of the Association of Physicians. 2016 Nov; 109(11):749-750. doi: 10.1093/qjmed/hcw163. [PMID: 27654501]
  • Yukari Yaju, Yaeko Kataoka, Hiromi Eto, Shigeko Horiuchi, Rintaro Mori. Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period. The Cochrane database of systematic reviews. 2013 Nov; ?(11):CD009328. doi: 10.1002/14651858.cd009328.pub2. [PMID: 24277681]
  • J E Dalziel, K E Dunstan, S C Finch. Combined effects of fungal alkaloids on intestinal motility in an in vitro rat model. Journal of animal science. 2013 Nov; 91(11):5177-82. doi: 10.2527/jas.2013-6449. [PMID: 23989880]
  • Maryam Pakfetrat, Akbar Rasekhi, Fatemeh Eftekhari, Nahid Hashemi, Jamshid Roozbeh, Simin Torabineghad, Leila Malekmakan. Ergotamine-induced acute tubulo-interstitial nephritis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2013 Sep; 24(5):981-3. doi: 10.4103/1319-2442.118100. [PMID: 24029265]
  • Chien C Wang, Liliana P Fernández, María Roxana Gómez. Sensitive ergotamine determination in pharmaceuticals and biological samples using cloud point preconcentration and spectrofluorimetric detection. Analytica chimica acta. 2013 Mar; 768(?):90-5. doi: 10.1016/j.aca.2013.01.023. [PMID: 23473254]
  • N Galeotti, C Ghelardini. St. John's wort relieves pain in an animal model of migraine. European journal of pain (London, England). 2013 Mar; 17(3):369-81. doi: 10.1002/j.1532-2149.2012.00196.x. [PMID: 23152076]
  • Gamze Demirel, Serife Suna Oguz, Omer Erdeve, Ugur Dilmen. Unilateral renal agenesis and urethral atresia associated with ergotamine intake during pregnancy. Renal failure. 2012; 34(5):643-4. doi: 10.3109/0886022x.2012.668156. [PMID: 22417229]
  • Dennis Mulac, Hans-Ulrich Humpf. Cytotoxicity and accumulation of ergot alkaloids in human primary cells. Toxicology. 2011 Apr; 282(3):112-21. doi: 10.1016/j.tox.2011.01.019. [PMID: 21295106]
  • Sanjeev Bhattacharyya, Anthony H Schapira, Dimitri P Mikhailidis, Joseph Davar. Drug-induced fibrotic valvular heart disease. Lancet (London, England). 2009 Aug; 374(9689):577-85. doi: 10.1016/s0140-6736(09)60252-x. [PMID: 19683643]
  • Cheng Peng, Xiaofang Xie, Lan Wang, Li Guo, Tanlian Hu. Pharmacodynamic action and mechanism of volatile oil from Rhizoma Ligustici Chuanxiong Hort. on treating headache. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2009 Jan; 16(1):25-34. doi: 10.1016/j.phymed.2008.10.010. [PMID: 19121572]
  • R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1385-405. doi: 10.1124/dmd.108.020479. [PMID: 18426954]
  • Thomas Haarmann, Nicole Lorenz, Paul Tudzynski. Use of a nonhomologous end joining deficient strain (Deltaku70) of the ergot fungus Claviceps purpurea for identification of a nonribosomal peptide synthetase gene involved in ergotamine biosynthesis. Fungal genetics and biology : FG & B. 2008 Jan; 45(1):35-44. doi: 10.1016/j.fgb.2007.04.008. [PMID: 17560817]
  • Maria Neve Ombra, Maria Musumeci, Jacques Simpore, Grazia Maria Palano, Salvatore Musumeci. beta-Endorphin concentration in colostrums of Burkinabe and Sicilian women. Nutrition (Burbank, Los Angeles County, Calif.). 2008 Jan; 24(1):31-6. doi: 10.1016/j.nut.2007.09.004. [PMID: 17981438]
  • T A Armer, S B Shrewsbury, S P Newman, G Pitcairn, N Ramadan. Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans. Current medical research and opinion. 2007 Dec; 23(12):3177-87. doi: 10.1185/030079907x242881. [PMID: 17991308]
  • Donata Favretto, Giampietro Frison, Susanna Vogliardi, Santo Davide Ferrara. Highly specific quantification of ergotamine in urine, blood, and hair samples by liquid chromatography-tandem mass spectrometry. Therapeutic drug monitoring. 2007 Jun; 29(3):325-32. doi: 10.1097/ftd.0b013e318067dfe7. [PMID: 17529890]
  • Christopher L Schardl, Daniel G Panaccione, Paul Tudzynski. Ergot alkaloids--biology and molecular biology. The Alkaloids. Chemistry and biology. 2006; 63(?):45-86. doi: 10.1016/s1099-4831(06)63002-2. [PMID: 17133714]
  • E Arzu Saglam, Alp Usubütün, Cavit Kart, Ali Ayhan, Türkan Küçükali. Reactive nodular fibrous pseudotumor involving the pelvic and abdominal cavity: a case report and review of literature. Virchows Archiv : an international journal of pathology. 2005 Nov; 447(5):879-82. doi: 10.1007/s00428-005-0027-y. [PMID: 16021510]
  • Fred De Clerck, Yves Somers, Erik Mannaert, Andrew Greenspan, Marielle Eerdekens. In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis. Clinical therapeutics. 2004 Aug; 26(8):1261-73. doi: 10.1016/s0149-2918(04)80097-3. [PMID: 15476907]
  • Franco Lombardo, R Scott Obach, Marina Y Shalaeva, Feng Gao. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry. 2004 Feb; 47(5):1242-50. doi: 10.1021/jm030408h. [PMID: 14971904]
  • Ali S Moubarak, Zelpha B Johnson, Charles F Rosenkrans. Antagonistic effects of simultaneous exposure of ergot alkaloids on kidney adenosine triphosphatase system. In vitro cellular & developmental biology. Animal. 2003 Sep; 39(8-9):395-8. doi: 10.1290/1543-706x(2003)039<0395:aeoseo>2.0.co;2. [PMID: 15038775]
  • Richard Browning. Effect of ergotamine on plasma metabolite and insulin-like growth factor-1 concentrations in cows. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP. 2003 May; 135(1):1-9. doi: 10.1016/s1532-0456(03)00048-6. [PMID: 12781836]
  • Stephen D Silberstein, Douglas C McCrory. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache. 2003 Feb; 43(2):144-66. doi: 10.1046/j.1526-4610.2003.03034.x. [PMID: 12558771]
  • Kazuto Yasuda, Lu-Bin Lan, Dominique Sanglard, Katryn Furuya, John D Schuetz, Erin G Schuetz. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. The Journal of pharmacology and experimental therapeutics. 2002 Oct; 303(1):323-32. doi: 10.1124/jpet.102.037549. [PMID: 12235267]
  • Franco Lombardo, R Scott Obach, Marina Y Shalaeva, Feng Gao. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. Journal of medicinal chemistry. 2002 Jun; 45(13):2867-76. doi: 10.1021/jm0200409. [PMID: 12061889]
  • Richard Browning, Frederick N Thompson. Endocrine and respiratory responses to ergotamine in Brahman and Hereford steers. Veterinary and human toxicology. 2002 Jun; 44(3):149-54. doi: . [PMID: 12046966]
  • Keiko Tsutsumi, Yasuko Obata, Tsuneji Nagai, Thorsteinn Loftsson, Kozo Takayama. Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. International journal of pharmaceutics. 2002 May; 238(1-2):161-70. doi: 10.1016/s0378-5173(02)00070-4. [PMID: 11996820]
  • Sean Ekins, Richard B Kim, Brenda F Leake, Anne H Dantzig, Erin G Schuetz, Lu-Bin Lan, Kazuto Yasuda, Robert L Shepard, Mark A Winter, John D Schuetz, James H Wikel, Steven A Wrighton. Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. Molecular pharmacology. 2002 May; 61(5):964-73. doi: 10.1124/mol.61.5.964. [PMID: 11961113]
  • C M Villalón, D Centurión, L F Valdivia, P De Vries, P R Saxena. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proceedings of the Western Pharmacology Society. 2002; 45(?):199-210. doi: . [PMID: 12434581]
  • R Browning, F N Schrick, F N Thompson, T Wakefield. Effect of an acute ergotamine challenge on reproductive hormones in follicular phase heifers and progestin-treated cows. Animal reproduction science. 2001 May; 66(3-4):135-49. doi: 10.1016/s0378-4320(01)00098-7. [PMID: 11348777]
  • N M Filipov, F N Thompson, J A Stuedemann, T H Elsasser, S Kahl, L H Stanker, C R Young, D L Dawe, C K Smith. Anti-inflammatory effects of ergotamine in steers. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 2000 Nov; 225(2):136-42. doi: 10.1046/j.1525-1373.2000.22517.x. [PMID: 11044256]
  • K Janssen van Doorn, P Van der Niepen, F van Tussenbroeck, D Verbeelen. Acute tubulo-interstitial nephritis and renal infarction secondary to ergotamine therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2000 Nov; 15(11):1877-9. doi: 10.1093/ndt/15.11.1877. [PMID: 11071983]
  • R Browning, S J Gissendanner, T Wakefield. Ergotamine alters plasma concentrations of glucagon, insulin, cortisol, and triiodothyronine in cows. Journal of animal science. 2000 Mar; 78(3):690-8. doi: 10.2527/2000.783690x. [PMID: 10764077]
  • R Browning. Physiological responses of Brahman and Hereford steers to an acute ergotamine challenge. Journal of animal science. 2000 Jan; 78(1):124-30. doi: 10.2527/2000.781124x. [PMID: 10682812]
  • P Egermayer. Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?. Journal of internal medicine. 2000 Jan; 247(1):11-7. doi: 10.1046/j.1365-2796.2000.00586.x. [PMID: 10672126]
  • N M Filipov, F N Thompson, M Tsunoda, R P Sharma. Region-specific decrease of dopamine and its metabolites in brains of mice given ergotamine. Journal of toxicology and environmental health. Part A. 1999 Jan; 56(1):47-58. doi: 10.1080/009841099158222. [PMID: 9923753]
  • C T Dougherty, F W Knapp, L P Bush. Mortality of horn fly larvae (Diptera: Muscidae) in bovine dung supplemented with ergotamine and N-formyl loline. Journal of medical entomology. 1999 Jan; 36(1):73-7. doi: 10.1093/jmedent/36.1.73. [PMID: 10071496]
  • K Stange, H Pohlmeier, A Lübbesmeyer, G Gumbinger, W Schmitz, P Baumgart. [Vascular ergotism through inhalation of grain dust]. Deutsche medizinische Wochenschrift (1946). 1998 Dec; 123(51-52):1547-50. doi: 10.1055/s-2007-1024221. [PMID: 9893681]
  • I Vogt Engeland, O Andresen, E Ropstad, H Kindahl, H Waldeland, A Daskin, L Olav Eik. Effect of fungal alkaloids on the development of pregnancy and endocrine foetal-placental function in the goat. Animal reproduction science. 1998 Oct; 52(4):289-302. doi: 10.1016/s0378-4320(98)00107-9. [PMID: 9821503]
  • P Jerie. [Cardiology in 1997]. Casopis lekaru ceskych. 1998 Oct; 137(19):585-9. doi: . [PMID: 9818470]
  • R L Rice, G G Schurig, D J Blodgett. Evaluation of physiologic indices in mice vaccinated with protein-ergotamine conjugates and fed an endophyte-infected fescue diet. American journal of veterinary research. 1998 Oct; 59(10):1258-62. doi: . [PMID: 9781458]
  • A MaassenVanDenBrink, M Reekers, W A Bax, M D Ferrari, P R Saxena. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998 Jul; 98(1):25-30. doi: 10.1161/01.cir.98.1.25. [PMID: 9665056]
  • R Browning, M L Leite-Browning, H M Smith, T Wakefield. Effect of ergotamine and ergonovine on plasma concentrations of thyroid hormones and cortisol in cattle. Journal of animal science. 1998 Jun; 76(6):1644-50. doi: 10.2527/1998.7661644x. [PMID: 9655585]
  • R Browning, F N Schrick, F N Thompson, T Wakefield. Reproductive hormonal responses to ergotamine and ergonovine in cows during the luteal phase of the estrous cycle. Journal of animal science. 1998 May; 76(5):1448-54. doi: 10.2527/1998.7651448x. [PMID: 9621953]
  • R L Rice, D J Blodgett, G G Schurig, W S Swecker, C D Thatcher, D E Eversole. Oral and parenteral vaccination of mice with protein-ergotamine conjugates and evaluation of protection against fescue toxicosis. Veterinary immunology and immunopathology. 1998 Feb; 61(2-4):305-16. doi: 10.1016/s0165-2427(97)00156-6. [PMID: 9613443]
  • S Sommer, B Delemazure, M Wagner, L Xenard, P Rozot. [Bilateral ischemic optic neuropathy secondary to acute ergotism]. Journal francais d'ophtalmologie. 1998 Feb; 21(2):123-5. doi: NULL. [PMID: 9759393]
  • S L Annis, D G Panaccione. Presence of peptide synthetase gene transcripts and accumulation of ergopeptines in Claviceps purpurea and Neotyphodium coenophialum. Canadian journal of microbiology. 1998 Jan; 44(1):80-6. doi: 10.1139/w97-130. [PMID: 9546869]
  • P Rolan. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90). Cephalalgia : an international journal of headache. 1997 Oct; 17 Suppl 18(?):21-7. doi: 10.1177/0333102497017s1804. [PMID: 9399014]
  • F G Boess, F J Monsma, V Meyer, C Zwingelstein, A J Sleight. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor. Molecular pharmacology. 1997 Sep; 52(3):515-23. doi: 10.1124/mol.52.3.515. [PMID: 9284367]
  • R Browning, F N Thompson, J L Sartin, M L Leite-Browning. Plasma concentrations of prolactin, growth hormone, and luteinizing hormone in steers administered ergotamine or ergonovine. Journal of animal science. 1997 Mar; 75(3):796-802. doi: 10.2527/1997.753796x. [PMID: 9078499]
  • N T Mathew. Dosing and administration of ergotamine tartrate and dihydroergotamine. Headache. 1997; 37 Suppl 1(?):S26-32. doi: . [PMID: 9009471]
  • S D Silberstein. The pharmacology of ergotamine and dihydroergotamine. Headache. 1997; 37 Suppl 1(?):S15-25. doi: . [PMID: 9009470]
  • R Browning, M L Leite-Browning. Effect of ergotamine and ergonovine on thermal regulation and cardiovascular function in cattle. Journal of animal science. 1997 Jan; 75(1):176-81. doi: 10.2527/1997.751176x. [PMID: 9027563]
  • R S Horowitz, R C Dart, H F Gomez. Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. Archives of internal medicine. 1996 Feb; 156(4):456-8. doi: . [PMID: 8607732]
  • T Murakami, K Sawada, K Taneda, M Hayashi, Y Katsuura, H Tanabe, M Kiyoki, H Araki. Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease. Arzneimittel-Forschung. 1995 Sep; 45(9):991-4. doi: ". [PMID: 7488320]
  • F Pietrogrande, A Caenazzo, F Dazzi, G Polato, A Girolami. A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report. Angiology. 1995 Jul; 46(7):633-6. doi: 10.1177/000331979504600712. [PMID: 7618768]
  • M N Schwarzberg. Application of metoclopramide specificity in migraine attacks therapy. Headache. 1994 Jul; 34(7):439-41. doi: 10.1111/j.1526-4610.1994.hed3407439.x. [PMID: 7928330]
  • B G Wolthers, W D Verhagen Kamerbeek, C M van Beusekom, F Elshof, A W de Ruyter Buitenhuis, E P Brunt, J P Lakke. Quantitative determination of the dopamine agonist lisuride in plasma using high-performance liquid chromatography with fluorescence detection. Journal of chromatography. 1993 Dec; 622(1):33-8. doi: 10.1016/0378-4347(93)80246-z. [PMID: 8120110]
  • T H Nielsen, P Tfelt-Hansen. No effect of the 5HT2-antagonist ICI 169,369 on systolic, ergotamine-induced blood pressure changes in man. Pharmacology & toxicology. 1993 Sep; 73(3):133-6. doi: 10.1111/j.1600-0773.1993.tb01550.x. [PMID: 8265515]
  • N Adham, H T Kao, L E Schecter, J Bard, M Olsen, D Urquhart, M Durkin, P R Hartig, R L Weinshank, T A Branchek. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proceedings of the National Academy of Sciences of the United States of America. 1993 Jan; 90(2):408-12. doi: 10.1073/pnas.90.2.408. [PMID: 8380639]
  • A B Chestnut, P D Anderson, M A Cochran, H A Fribourg, K D Gwinn. Effects of hydrated sodium calcium aluminosilicate on fescue toxicosis and mineral absorption. Journal of animal science. 1992 Sep; 70(9):2838-46. doi: 10.2527/1992.7092838x. [PMID: 1328128]
  • G W Meijer, G B Janssen, A C Beynen, G J Speijers. Is dietary ergotamine atherogenic in the rabbit?. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 1992 Aug; 30(8):731-4. doi: 10.1016/0278-6915(92)90171-g. [PMID: 1398355]
  • M O Den Boer, J A Somers, P R Saxena. Comparative effects of the antimigraine drugs sumatriptan and ergotamine on the distribution of cardiac output in anaesthetized pigs. Cephalalgia : an international journal of headache. 1992 Aug; 12(4):206-13. doi: 10.1046/j.1468-2982.1992.1204206.x. [PMID: 1326403]
  • G McAllister, A Charlesworth, C Snodin, M S Beer, A J Noble, D N Middlemiss, L L Iversen, P Whiting. Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proceedings of the National Academy of Sciences of the United States of America. 1992 Jun; 89(12):5517-21. doi: 10.1073/pnas.89.12.5517. [PMID: 1608964]
  • J W Lance. The pathophysiology of migraine: a tentative synthesis. Pathologie-biologie. 1992 Apr; 40(4):355-60. doi: NULL. [PMID: 1379708]
  • N Feng, E I Minder, T Grampp, D J Vonderschmitt. Identification and quantification of ergotamine in human plasma by gas chromatography-mass spectrometry. Journal of chromatography. 1992 Mar; 575(2):289-94. doi: 10.1016/0378-4347(92)80159-n. [PMID: 1629307]
  • J Lund. Prolonged renal impairment after chronic ergotamine intoxication. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1992; 7(8):879-80. doi: 10.1093/ndt/7.8.879. [PMID: 1325625]
  • M Nicolodi, F Sicuteri. Links between headache mechanisms and new medications. The Clinical journal of pain. 1991; 7 Suppl 1(?):S64-71. doi: . [PMID: 1810524]
  • T E Groomes, C T Huang. Orthostatic hypotension after spinal cord injury: treatment with fludrocortisone and ergotamine. Archives of physical medicine and rehabilitation. 1991 Jan; 72(1):56-8. doi: . [PMID: 1985624]
  • S Diamond. Management of headaches. Focus on new strategies. Postgraduate medicine. 1990 Mar; 87(4):189-92, 195. doi: 10.1080/00325481.1990.11704605. [PMID: 2315245]
  • E Sartori, M Delaforge. Specific drug binding to rat liver cytochrome P-450 isozymes induced by pregnenolone-16 alpha-carbonitrile and macrolide antibiotics. Implications for drug interactions. Chemico-biological interactions. 1990; 73(2-3):297-307. doi: 10.1016/0009-2797(90)90010-k. [PMID: 2107034]
  • N Häring, Z Salama, H Jaeger. Triple stage quadrupole mass spectrometric determination of bromocriptine in human plasma with negative ion chemical ionization. Arzneimittel-Forschung. 1988 Oct; 38(10):1529-32. doi: NULL. [PMID: 3196397]
  • J Barquinero Máñez, J L Tovar Méndez, M Vallès Prats, A de Luis Sánchez. [Ergotamine and acute renal insufficiency]. Medicina clinica. 1987 Jan; 88(2):80-1. doi: NULL. [PMID: 3821266]
  • P M Bülow, J J Ibraheem, G Paalzow, P Tfelt-Hansen. Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine. Cephalalgia : an international journal of headache. 1986 Jun; 6(2):107-11. doi: 10.1046/j.1468-2982.1986.0602107.x. [PMID: 3091257]
  • S W Sanders, N Haering, H Mosberg, H Jaeger. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. European journal of clinical pharmacology. 1986; 30(3):331-4. doi: 10.1007/bf00541538. [PMID: 3732370]
  • V L Perrin. Clinical pharmacokinetics of ergotamine in migraine and cluster headache. Clinical pharmacokinetics. 1985 Jul; 10(4):334-52. doi: 10.2165/00003088-198510040-00004. [PMID: 3899452]
  • N Haering, J A Settlage, S W Sanders, R Schuberth. Measurement of ergotamine in human plasma by triple sector quadrupole mass spectrometry with negative ion chemical ionization. Biomedical mass spectrometry. 1985 May; 12(5):197-9. doi: 10.1002/bms.1200120503. [PMID: 3161549]
  • R Pujadas, J Argimón, A Pelegrí, J Jané. [Renal insufficiency and ergotism]. Medicina clinica. 1985 Feb; 84(5):208-9. doi: NULL. [PMID: 3920451]
  • P Tfelt-Hansen, L Paalzow. Intramuscular ergotamine: plasma levels and dynamic activity. Clinical pharmacology and therapeutics. 1985 Jan; 37(1):29-35. doi: 10.1038/clpt.1985.7. [PMID: 3917386]
  • J J Ibraheem, L Paalzow, P Tfelt-Hansen. Linear pharmacokinetics of intravenous ergotamine tartrate. European journal of clinical pharmacology. 1985; 29(1):61-6. doi: 10.1007/bf00547370. [PMID: 3932078]
  • A N Graham, E S Johnson, N P Persaud, P Turner, M Wilkinson. Ergotamine toxicity and serum concentrations of ergotamine in migraine patients. Human toxicology. 1984 Jun; 3(3):193-9. doi: 10.1177/096032718400300304. [PMID: 6430784]
  • H Francis, A Tyndall, J Webb. Severe vascular spasm due to erythromycin-ergotamine interaction. Clinical rheumatology. 1984 Jun; 3(2):243-6. doi: 10.1007/bf02030764. [PMID: 6236021]
  • J Rosenthaler, H Munzer, R Voges, H Andres, P Gull, G Bolliger. Immunoassay of ergotamine and dihydroergotamine using a common 3H-labelled ligand as tracer for specific antibody and means to overcome experienced pitfalls. International journal of nuclear medicine and biology. 1984; 11(1):85-9. doi: 10.1016/0047-0740(84)90040-8. [PMID: 6735611]
  • P Tfelt-Hansen, I L Kanstrup, N J Christensen, K Winkler. General and regional haemodynamic effects of intravenous ergotamine in man. Clinical science (London, England : 1979). 1983 Dec; 65(6):599-604. doi: 10.1042/cs0650599. [PMID: 6627846]
  • J J Ibraheem, L Paalzow, P Tfelt-Hansen. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. British journal of clinical pharmacology. 1983 Dec; 16(6):695-9. doi: 10.1111/j.1365-2125.1983.tb02243.x. [PMID: 6419759]
  • D L Vesely. Ergotamine and dihydroergotamine enhance guanylate cyclase activity. Research communications in chemical pathology and pharmacology. 1983 May; 40(2):245-54. doi: . [PMID: 6136069]
  • K Ekbom, A E Krabbe, G Paalzow, L Paalzow, P Tfelt-Hansen, E Waldenlind. Optimal routes of administration of ergotamine tartrate in cluster headache patients. A pharmacokinetic study. Cephalalgia : an international journal of headache. 1983 Mar; 3(1):15-20. doi: 10.1046/j.1468-2982.1983.0301015.x. [PMID: 6406071]
  • A V Chobanian, C P Tifft, D P Faxon, M A Creager, H Sackel. Treatment of chronic orthostatic hypotension with ergotamine. Circulation. 1983 Mar; 67(3):602-9. doi: 10.1161/01.cir.67.3.602. [PMID: 6295662]
  • V Ala-Hurula, V Myllylä, E Hokkanen. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia : an international journal of headache. 1982 Dec; 2(4):189-95. doi: 10.1046/j.1468-2982.1982.0204189.x. [PMID: 7159921]
  • H Hovdal, G B Syversen, J Rosenthaler. Ergotamine in plasma and CSF after i.m. and rectal administration to humans. Cephalalgia : an international journal of headache. 1982 Sep; 2(3):145-50. doi: 10.1046/j.1468-2982.1982.0203145.x. [PMID: 7151147]
  • V Ala-Hurula. Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine. European journal of clinical pharmacology. 1982; 21(5):397-402. doi: 10.1007/bf00542326. [PMID: 7075645]
  • J J Ibraheem, L Paalzow, P Tfelt-Hansen. Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. European journal of clinical pharmacology. 1982; 23(3):235-40. doi: 10.1007/bf00547560. [PMID: 7173294]
  • D A Orton, R J Richardson. Ergotamine absorption and toxicity. Postgraduate medical journal. 1982 Jan; 58(675):6-11. doi: 10.1136/pgmj.58.675.6. [PMID: 7088766]
  • K Ekbom, L Paalzow, E Waldenlind. Low biological availability of ergotamine tartrate after oral dosing in cluster headache. Cephalalgia : an international journal of headache. 1981 Dec; 1(4):203-7. doi: 10.1046/j.1468-2982.1981.0104203.x. [PMID: 6812961]
  • P O Edlund. Determination of ergot alkaloids in plasma by high-performance liquid chromatography and fluorescence detection. Journal of chromatography. 1981 Nov; 226(1):107-15. doi: 10.1016/s0378-4347(00)84211-5. [PMID: 6895636]